Based on the Celcuity LLC stock forecast from 5 analysts, the average analyst target price for Celcuity LLC is USD 29.63 over the next 12 months. Celcuity LLC’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Celcuity LLC is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Celcuity LLC’s stock price was USD 12.46. Celcuity LLC’s stock price has changed by -0.48% over the past week, -2.12% over the past month and -14.89% over the last year.
No recent analyst target price found for Celcuity LLC
No recent average analyst rating found for Celcuity LLC
Company Overview Celcuity LLC
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer, and metastatic castration resistant prostate cancer. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota. Read Less
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnorma...Read More
Frequently Asked Questions About Celcuity LLC (CELC) Stock
Based on ratings from 5 analysts Celcuity LLC's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 8 buy, sell and hold ratings.
Unfortunately we do not have enough data on CELC's stock to indicate if its a good dividend stock.
Based on targets from 5 analysts, the average taret price for CELC is USD 29.63 over the next 12 months. The maximum analyst target price is USD 42 while the minimum anlayst target price is USD 23.
Unfortunately we do not have enough data on CELC's stock to indicate if its overvalued.
The last closing price of CELC's stock was USD 12.46.
The most recent market capitalization for CELC is USD 0.46B.
Based on targets from 5 analysts, the average taret price for CELC is projected at USD 29.63 over the next 12 months.
This means that CELC's stock price may go up by +137.76% over the next 12 months.
We can't find any ETFs which contains Celcuity LLC's stock.
As per our most recent records Celcuity LLC has 55 Employees.
Celcuity LLC's registered address is 16305?36th Avenue North, Minneapolis, MN, United States, 55446.
You can get more information about it from Celcuity LLC's website at https://www.celcuity.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Frequently Asked Questions About Celcuity LLC (CELC) Stock
Based on ratings from 5 analysts Celcuity LLC's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 8 buy, sell and hold ratings.
Unfortunately we do not have enough data on CELC's stock to indicate if its a good dividend stock.
Based on targets from 5 analysts, the average taret price for CELC is USD 29.63 over the next 12 months. The maximum analyst target price is USD 42 while the minimum anlayst target price is USD 23.
Unfortunately we do not have enough data on CELC's stock to indicate if its overvalued.
The last closing price of CELC's stock was USD 12.46.
The most recent market capitalization for CELC is USD 0.46B.
Based on targets from 5 analysts, the average taret price for CELC is projected at USD 29.63 over the next 12 months.
This means that CELC's stock price may go up by +137.76% over the next 12 months.
We can't find any ETFs which contains Celcuity LLC's stock.
As per our most recent records Celcuity LLC has 55 Employees.
Celcuity LLC's registered address is 16305?36th Avenue North, Minneapolis, MN, United States, 55446.
You can get more information about it from Celcuity LLC's website at https://www.celcuity.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for CELC !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
